After graduation from UC Davis with a MS in Analytical Biochemistry in 1974, Kerry Nugent spent seven years with Shell Oil in their Biological Sciences Research Center in Modesto, California, as an analytical chemist working on methods for trace level analysis of pesticides and metabolites by HPLC. Kerry then spent seven years with IBM in their Scientific Instrument Division in various roles including HPLC instrument development, applications development, sales and biotechnology market development.
Following the closing of this IBM division, he spent two years at Bionovus, a venture capital startup company that attempted to develop an automated 2D system that coupled capillary HPLC to gel electrophorisis. In 1989, Kerry started Michrom BioResources, a company that specialized in HPLC instrumentation and applications for biotechnology and pharmaceutical scientists. The company grew over the next 20 years and manufactured a wide range of products for HPLC and LC/MS of biological samples. In 2011, Michrom was purchased by Bruker and Kerry served as a Senior Vice President in charge of Bruker’s LC Division. In June, 2014, Kerry left Bruker to start a new venture (WarpLCMS) that markets a novel UHPLC column for very high throughput LCMS applications in clinical and pharmaceutical markets.